© Copyright khedmeh Wall
The duration of lenvatinib treatment depends on the type of cancer being treated, how the patient responds to the drug, and how well they tolerate it. Lenvatinib is mainly used for the following types of cancer:
Thyroid cancer (differentiated thyroid cancer, used when radioactive iodine treatment is not effective)
Renal cell carcinoma (often in combination with pembrolizumab)
Hepatocellular carcinoma (liver cancer)
Endometrial cancer (in combination with pembrolizumab for some advanced cases)
Factors affecting duration:
Response to treatment: If the cancer responds well to lenvatinib, patients may continue taking the drug for months or years, depending on how long the cancer remains stable or shows regression and Lenvatinib Price Malaysia.
Side effects: Like any targeted therapy, lenvatinib can have side effects, such as high blood pressure, fatigue, gastrointestinal problems, and changes in liver enzymes. If side effects become severe or intolerable, treatment may be adjusted or stopped.
Disease progression: If cancer progresses despite treatment, or if lenvatinib becomes ineffective, it may be stopped in favor of alternative treatments.
Combination therapy: Lenvatinib is often used in combination with other drugs (e.g., pembrolizumab for endometrial cancer and renal cell carcinoma). The duration of treatment depends on how well the combination works for the individual.
Treatment plan:
Initial phase: Lenvatinib is usually started with a standard dose, and doctors will regularly assess its effectiveness.
Ongoing therapy: Many patients continue treatment as long as the drug is controlling the cancer and side effects are manageable.
Discontinuation: Treatment may be stopped if the cancer becomes resistant, progresses, or there are intolerable side effects.
In general, lenvatinib is a long-term treatment, but the exact duration should be determined based on the patient's response and overall health, as well as regular evaluation by an oncologist and Lenvatinib Price Philippines.
The Wall